Carboplatin

Introduction: Carboplatin

Description of Carboplatin

Carboplatin: A platinum-containing anticancer agent much like cisplatin but more toxic to the myeloid elements of bone marrow while producing less nausea and neuro-, oto-, and nephrotoxicity; used in the chemotherapy of solid tumors.
Source: Stedman's Medical Spellchecker, © 2006 Lippincott Williams & Wilkins. All rights reserved.

Carboplatin: An anticancer drug that belongs to the family of drugs called platinum compounds.
Source: National Institute of Health

Carboplatin: A second-generation platinum compound with a broad spectrum of antineoplastic properties. Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue. This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)
Source: Diseases Database

Carboplatin: organoplatinum compound with antineoplastic activity.
Source: CRISP

Carboplatin: An organoplatinum compound that possesses antineoplastic activity.
Source: MeSH 2007

Carboplatin: Related Topics

These medical condition or symptom topics may be relevant to medical information for Carboplatin:

Abbreviation: Carboplatin

Carboplatin: An abbreviation for:
Source: CRISP

CBDCA

Drug name confusion

Because many drug names share similar spellings or sound almost identical when spoken, it is possible to mistake the name of a particular medication. Other drugs that are sometimes confused with Carboplatin include: